https://www.selleckchem.com/pr....oducts/purmorphamine
Compared with non-severe COVID-19 patients, systemic levels of IL-6 and IL-10, but not TNF-α, were significantly elevated in severe COVID-19 patients (MD = 18.63, 95% CI 10.91, 26.35, P 0.00001; MD = 2.61, 95% CI 2.00, 2.32, P 0.00001; respectively). For COVID-19 mortality, circulating levels of IL-6, IL-10, and TNF-α were found to be significantly increased in non-survivors when compared with survivors (MD = 57.82, 95% CI 10.04, 105.59, P = 0.02; MD = 4.94, 95% CI 3.89, 6.00, P 0.00001; MD = 5.60, 95% CI 4.03, 7.17
Like
Comment
Share
